December 05, 2025

Fancy Gadgets, Higher Bills: HSA Era

Republican proposals to expand health savings accounts amid expiring ACA subsidies outline potential shifts in coverage costs and limitations in how patients may use HSA funds.

KFF Health News

December 04, 2025

HHS Communications in Transition

Why HHS messaging is shifting, and what it means for patient trust.

KFF Health News

December 03, 2025

Are New Incentives Boosting Births?

A report on recent federal pronatalist policy initiatives, proposed IVF access measures, and associated government actions involving women’s and children’s health programs in the US.

KFF Health News

November 24, 2025

Why Youth E-Bike Injuries Are Increasing

Rising youth e-bike use and injuries amid limited federal oversight and evolving state safety rules.

KFF Health News

November 21, 2025

‘Gold-Standard Science’ Meets a Rewrite

Revisions to a key CDC webpage have unsettled clinicians, who worry the changes could erode confidence in established vaccine science.

KFF Health News

November 13, 2025

‘FDA Said Yes, Despite Inconclusive Evidence’

The FDA’s authorization of the Q-Collar is under scrutiny after researchers identified duplicated data, altered study endpoints, and unsubstantiated “brain protection” claims.

Conexiant

November 10, 2025

FDA Proposes Removal of Box Warnings

The FDA proposed updates to menopausal hormone therapy labeling to reflect current evidence on benefits and risks.

Conexiant

November 06, 2025

‘Wasteful’? Doctors Call It Essential

Proposed cuts to the Hospital Preparedness Program may limit hospitals’ capacity to manage pandemics, natural disasters, and mass-casualty events affecting U.S. health systems.

KFF Health News

November 06, 2025

Lumateperone Approved for Major Depression

The atypical antipsychotic demonstrated statistically significant improvements over placebo in two phase 3 trials, with separation from placebo emerging within 1 to 2 weeks and 65% of patients achieving remission at 6 months.

Conexiant